Portland, OR -- (SBWIRE) -- 09/29/2017 -- The global nuclear medicine equipment market was valued at $2,012 million in 2015, and is estimated to reach $2,647 million by 2022, growing at a CAGR of 3.9% during the forecast period. Nuclear medicine utilizes radionuclides, which are unstable atoms that emit radiation spontaneously, to examine and treat diseases such as, cancer, cardiovascular, and others.
Early buyer will get flat 30% Discount..!!!
The nuclear medicine equipment market is segmented based on product type, application, end user, and geography. Based on product, the market is divided into SPECT, which is further segmented into standalone, and hybrid SPECT, and PET is subcategorized as standalone and hybrid PET. By application, it is categorized into cardiology, neurology, oncology, and others (orthopedics, urology, thyroid-related disorders, and gastroenterology). Based on end user, it is segmented into hospitals, imaging centers, and academic & research institutes. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, Argentina, and rest of LAMEA).
Hospitals dominated with around two-fifths of the global market value in 2015, and are expected to continue this trend during the forecast period. The number of patients visiting hospitals is growing to due increase in the occurrence of chronic diseases, which has fueled the market growth for this segment.
Get PDF of this Report @ https://www.alliedmarketresearch.com/request-sample/1828
North America dominated the market in 2015, and is maintain its position in the future, due to the presence of a large geriatric population, technological advancements, availability of favorable imbursement policies, and affordability to purchase modern and expensive nuclear medicine equipment.
NUCLEAR MEDICINE EQUIPMENT MARKET KEY FINDINGS:
- Hybrid PET segment is projected to grow at the highest rate during the analysis period.
- Argentina nuclear medicine equipment market is estimated to grow at a CAGR of 6.0%.
- Oncology dominated the global nuclear medicine equipment market in 2015.
- U.S. was the largest market in 2015, and is projected to maintain its lead until 2022.
- Hospitals segment is projected to dominate throughout 2022.
Key players profiled in this report are General Electric Company, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Digirad Corporation, Mediso Medical Imaging Systems, Ltd., Toshiba Corporation, Bozlu Holding, Neusoft Corporation, Compañía Mexicana de Radiología CGR, S.A de C.V., and SurgicEye GmbH. Other players operating in this market include CMR Naviscan Corporation, DDD-Diagnostic A/S, Positron Corporation, and TeraRecon, Inc.